(Q44973715)

7 December 2017

Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma (English)

1 reference

7 December 2017

5

Jörg-Christian Tonn

0 references

Gabriele Pöpperl

series ordinal

1

object named as

Gabriele Pöpperl

0 references

Franz-Josef Gildehaus

series ordinal

4

object named as

Franz-Josef Gildehaus

0 references

Walter Rachinger

series ordinal

3

object named as

Walter Rachinger

1 reference

7 December 2017

6

Klaus Tatsch

1 reference

7 December 2017

Claudia Götz

2

1 reference

7 December 2017

10 July 2004

1 reference

7 December 2017

7

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

7 December 2017

31

1 reference

7 December 2017

11

1 reference

7 December 2017

1464-1470

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-004-1590-1

7 December 2017

0 references

cites work

Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-L-tyrosine.

1 reference

12 December 2020

Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas

1 reference

12 December 2020

Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.

1 reference

12 December 2020

Imaging of brain tumors after therapy.

1 reference

12 December 2020

Fluorinated amino acids for tumour imaging with positron emission tomography

1 reference

12 December 2020

Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo.

1 reference

12 December 2020

The use of PET in evaluating patients with primary brain tumours: is it useful?

1 reference

12 December 2020

PET study of methionine accumulation in glioma and normal brain tissue: competition with branched chain amino acids.

1 reference

12 December 2020

"Facilitated" amino acid transport is upregulated in brain tumors.

1 reference

12 December 2020

18F alpha-methyl tyrosine PET studies in patients with brain tumors.

1 reference

12 December 2020

(18)F-FDG and (18)F-FET uptake in experimental soft tissue infection

1 reference

12 December 2020

PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome

1 reference

12 December 2020

O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study

1 reference

12 December 2020

Radiation injury of the brain

1 reference

12 December 2020

Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy.

1 reference

12 December 2020

Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury.

1 reference

12 December 2020

Brain tumors: L-[1-C-11]tyrosine PET for visualization and quantification of protein synthesis rate

1 reference

12 December 2020

3-O-methyl-6-[18F]fluoro-L-DOPA and its evaluation in brain tumour imaging

1 reference

12 December 2020

Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms.

1 reference

12 December 2020

11C-methionine PET for differential diagnosis of low-grade gliomas.

1 reference

12 December 2020

Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool

1 reference

12 December 2020

Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography?

1 reference

12 December 2020

Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas

1 reference

12 December 2020

Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference.

1 reference

12 December 2020

Enhanced accuracy in differential diagnosis of radiation necrosis by positron emission tomography-magnetic resonance imaging coregistration: technical case report.

1 reference

12 December 2020

Locoregional radioimmunotherapy in selected patients with malignant glioma: experiences, side effects and survival times.

1 reference

12 December 2020

Intracavitary Chemotherapy for Glioblastoma: Present Status and Future Directions

1 reference

12 December 2020

Gliomatosis cerebri evaluated by 18Falpha-methyl tyrosine positron-emission tomography

1 reference

12 December 2020

Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies.

1 reference

12 December 2020

Methyl-[11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma

1 reference

12 December 2020

Cerebral glioma: evaluation with methionine PET.

1 reference

12 December 2020

[11C]L-methionine uptake in gliomas.

1 reference

12 December 2020

Increased amino acid transport into brain tumors measured by PET of L-(2-18F)fluorotyrosine.

1 reference

12 December 2020

Brain tumour imaging with PET: a comparison between [ 18 F]fluorodopa and [ 11 C]methionine

1 reference

12 December 2020

Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?

1 reference

12 December 2020

Imaging experimental brain tumors with 1-aminocyclopentane carboxylic acid and alpha-aminoisobutyric acid: comparison to fluorodeoxyglucose and diethylenetriaminepentaacetic acid in morphologically defined tumor regions.

1 reference

12 December 2020

Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging.

1 reference

12 December 2020

10.1007/S00259-004-1590-1

Identifiers

DOI

1 reference

7 December 2017

1 reference

PubMed ID

15248032